Search Results - "Molecular therapy"

Refine Results
  1. 1

    Current Clinical Applications of In Vivo Gene Therapy with AAVs by Mendell, Jerry R., Al-Zaidy, Samiah A., Rodino-Klapac, Louise R., Goodspeed, Kimberly, Gray, Steven J., Kay, Christine N., Boye, Sanford L., Boye, Shannon E., George, Lindsey A., Salabarria, Stephanie, Corti, Manuela, Byrne, Barry J., Tremblay, Jacques P.

    Published in Molecular therapy (03-02-2021)
    “…Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases affect over 30 million Americans. For more than 30 years, hundreds of…”
    Get full text
    Journal Article
  2. 2

    Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery by Kowalski, Piotr S., Rudra, Arnab, Miao, Lei, Anderson, Daniel G.

    Published in Molecular therapy (10-04-2019)
    “…mRNA has broad potential as a therapeutic. Current clinical efforts are focused on vaccination, protein replacement therapies, and treatment of genetic…”
    Get full text
    Journal Article
  3. 3

    Immune Responses to Viral Gene Therapy Vectors by Shirley, Jamie L., de Jong, Ype P., Terhorst, Cox, Herzog, Roland W.

    Published in Molecular therapy (04-03-2020)
    “…Several viral vector-based gene therapy drugs have now received marketing approval. A much larger number of additional viral vectors are in various stages of…”
    Get full text
    Journal Article
  4. 4

    AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer by Costa Verdera, Helena, Kuranda, Klaudia, Mingozzi, Federico

    Published in Molecular therapy (04-03-2020)
    “…Gene therapy with adeno-associated virus (AAV) vectors has demonstrated safety and long-term efficacy in a number of trials across target organs, including…”
    Get full text
    Journal Article
  5. 5

    circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer by Sang, Yuting, Chen, Bing, Song, Xiaojin, Li, Yaming, Liang, Yiran, Han, Dianwen, Zhang, Ning, Zhang, Hanwen, Liu, Ying, Chen, Tong, Li, Chen, Wang, Lijuan, Zhao, Wenjing, Yang, Qifeng

    Published in Molecular therapy (04-09-2019)
    “…Tamoxifen is the most commonly used endocrine therapy for patients with hormone receptor (HR)-positive breast cancer. Despite its initial therapeutic efficacy,…”
    Get full text
    Journal Article
  6. 6

    Lipid Nanoparticle Systems for Enabling Gene Therapies by Cullis, Pieter R., Hope, Michael J.

    Published in Molecular therapy (05-07-2017)
    “…Genetic drugs such as small interfering RNA (siRNA), mRNA, or plasmid DNA provide potential gene therapies to treat most diseases by silencing pathological…”
    Get full text
    Journal Article
  7. 7

    Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication by Kloss, Christopher C., Lee, Jihyun, Zhang, Aaron, Chen, Fang, Melenhorst, Jan Joseph, Lacey, Simon F., Maus, Marcela V., Fraietta, Joseph A., Zhao, Yangbing, June, Carl H.

    Published in Molecular therapy (05-07-2018)
    “…Cancer has an impressive ability to evolve multiple processes to evade therapies. While immunotherapies and vaccines have shown great promise, particularly in…”
    Get full text
    Journal Article
  8. 8

    mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases by Maruggi, Giulietta, Zhang, Cuiling, Li, Junwei, Ulmer, Jeffrey B., Yu, Dong

    Published in Molecular therapy (10-04-2019)
    “…In the last two decades, there has been growing interest in mRNA-based technology for the development of prophylactic vaccines against infectious diseases…”
    Get full text
    Journal Article
  9. 9

    CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality? by Wagner, Jessica, Wickman, Elizabeth, DeRenzo, Christopher, Gottschalk, Stephen

    Published in Molecular therapy (04-11-2020)
    “…Chimeric antigen receptor (CAR) T cell therapy has garnered significant excitement due to its success for hematological malignancies in clinical studies…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses by Bahl, Kapil, Senn, Joe J., Yuzhakov, Olga, Bulychev, Alex, Brito, Luis A., Hassett, Kimberly J., Laska, Michael E., Smith, Mike, Almarsson, Örn, Thompson, James, Ribeiro, Amilcar (Mick), Watson, Mike, Zaks, Tal, Ciaramella, Giuseppe

    Published in Molecular therapy (07-06-2017)
    “…Recently, the World Health Organization confirmed 120 new human cases of avian H7N9 influenza in China resulting in 37 deaths, highlighting the concern for a…”
    Get full text
    Journal Article
  12. 12

    Emerging mechanisms and targeted therapy of ferroptosis in cancer by Wang, Haiyan, Cheng, Yan, Mao, Chao, Liu, Shuang, Xiao, Desheng, Huang, Jun, Tao, Yongguang

    Published in Molecular therapy (07-07-2021)
    “…Ferroptosis is an iron- and lipid reactive oxygen species (ROS)-dependent form of programmed cell death that is distinct from other forms of regulatory cell…”
    Get full text
    Journal Article
  13. 13

    COVID-19 mRNA vaccines: Platforms and current developments by Szabó, Gábor Tamás, Mahiny, Azita Josefine, Vlatkovic, Irena

    Published in Molecular therapy (04-05-2022)
    “…Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine agent in a preclinical study nearly 30 years ago, numerous advances…”
    Get full text
    Journal Article
  14. 14

    Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy by Duan, Dongsheng

    Published in Molecular therapy (03-10-2018)
    “…Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by dystrophin gene mutation. Conceptually, replacing the mutated gene with a normal one…”
    Get full text
    Journal Article
  15. 15

    ncRNA-Encoded Peptides or Proteins and Cancer by Wang, Jizhong, Zhu, Song, Meng, Nan, He, Yutian, Lu, Ruixun, Yan, Guang-Rong

    Published in Molecular therapy (02-10-2019)
    “…Non-coding RNAs (ncRNAs) are unique RNA transcripts that have been widely identified in the eukaryotic genome and have been shown to play key roles in the…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2 by Yang, Yuhan, Guo, Zengya, Chen, Weiwei, Wang, Xiaofeng, Cao, Meng, Han, Xuan, Zhang, Kundong, Teng, Buwei, Cao, Jun, Wu, Weidong, Cao, Peng, Huang, Chen, Qiu, Zhengjun

    Published in Molecular therapy (03-03-2021)
    “…Pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive tumors all over the world, has a generally poor prognosis, and its progression is…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment by Xu, Zijie, Chen, Yi, Ma, Ling, Chen, Yizhang, Liu, Jingya, Guo, Yuchen, Yu, Ting, Zhang, Lianghui, Zhu, Lingjun, Shu, Yongqian

    Published in Molecular therapy (05-10-2022)
    “…Exosomes have a crucial role in intercellular communication and mediate interactions between tumor cells and tumor-associated macrophages (TAMs)…”
    Get full text
    Journal Article